Jeannie Fontana, MD-PhD, a trailblazer in healthcare and ALS research funding, joins Robin Carhart-Harris, the founder of the Center for Psychedelic Research. They explore the TREAT Initiative in California, aiming to secure vital funding for psychedelic treatments in mental health. The conversation covers the legal landscape for psychedelics, the importance of safe therapeutic practices, and ongoing advocacy efforts. They also delve into the neuroscience behind psychedelics, discussing their potential for treating conditions like PTSD and their impact on brain function.

Jeannie Fontana and Robin Carhart-Harris discuss the Treat California initiative, the therapeutic potential of psychedelics, and the future applications of psychedelic medicine. They emphasize the need for large-scale clinical trials, patient education, and accessibility. The chapter also explores the financial challenges of conducting well-run studies, the effects of psychedelic drugs on the brain, and the need for non-denominational dialogue.

Sam Harris speaks with Jeannie Fontana and Robin Carhart-Harris about the TREAT Initiative in California and the growing promise of psychedelics for mental health care. They discuss the therapeutic potential of psychedelics, the current landscape of psychedelic medicine, the approval process for psychedelic medicine, the costs and funding of well-run studies, the effects of classic serotoninergic psychedelics on the brain, and a modern approach to organized religion and unity.